DZ Bank Discount Zert NAG 28.06.2.../ DE000DW8TYG8 /
27/05/2024 12:34:21 | Var.+0.290 | Denaro21:55:01 | Lettera- | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
67.360EUR | +0.43% | - Quantità in denaro: - |
- Quantità in lettera: - |
NAGARRO SE | - - | 28/06/2024 | Call |
GlobeNewswire
12:39
SQUARESPACE ALERT: Is $44 Per Share Too Low for Squarespace (NYSE: SQSP)? BFA Law is Investigating a...
GlobeNewswire
12:36
SPROUT SOCIAL NOTICE: If You Suffered Losses on Your Sprout Social (Nasdaq: SPT) Investment, You are...
GlobeNewswire
12:33
POWERSCHOOL ALERT: Is $22.80 Per Share Too Low for PowerSchool (NYSE: PWSC)? BFA Law is Investigatin...
GlobeNewswire
12:31
UIPATH NOTICE: If You Suffered Losses When UiPath, Inc.’s (NYSE: PATH) Stock Dropped 34%, You are Re...
GlobeNewswire
12:30
Park Hotels & Resorts Announces Second Quarter 2024 Earnings Conference Call on August 1, 2024
GlobeNewswire
12:30
Fastly ALERT: Securities Fraud Lawsuit Could Allow Investors to Recover Losses; Block & Leviton Enco...
GlobeNewswire
12:28
CEREVEL ALERT: Is $45 Per Share Too Low for Cerevel (Nasdaq: CERE)? BFA Law is Investigating and Urg...
GlobeNewswire
12:00
Liberty Gold Announces Approval of the Fourth Plan of Operations Amendment, Black Pine Oxide Gold Pr...
GlobeNewswire
12:00
RadNet, Inc. to Present at the Sidoti & Company 2024 Small Cap Conference on Wednesday, June 12th
GlobeNewswire
12:00
SiteMinder and Cloudbeds partner to create new distribution and revenue opportunities for hotels
GlobeNewswire
12:00
Digihost Expands Bitcoin Mining Operations with 11,000 S21s Increasing Hashing Rate to 3.2 EH/s
GlobeNewswire
12:00
Kepler Validates SDA-Compatible Optical Technology For Space Data Relay Constellation
GlobeNewswire
12:00
FreedomPay Launches Industry’s First Independent Payment Processing Referral Advisory for Merchants
GlobeNewswire
12:00
Iveco Group signs a 150 million euro term loan facility with Cassa Depositi e Prestiti to support in...
GlobeNewswire
12:00
NMD Pharma Initiates Phase 2b Trial of NMD670 in Generalized Myasthenia Gravis Patients